On July 10, 1989, Boise's board created a new series of convertible preferred stock
especially for the ESOP.
NEW YORK -- Phillips-Van Heusen Corporation (NYSE: PVH) today announced it has filed a prospectus supplement relating to the public offering by holders of its Series B Convertible Preferred Stock
of 10,057,495 shares of common stock (plus an additional 1,508,624 shares of common stock pursuant to an option granted to the underwriters) issuable upon the conversion of shares of the Company's Series B Convertible Preferred Stock
75% Noncumulative Preferred Stock, Series E (Series E Convertible Preferred Stock
), the conversion price of Series E Convertible Preferred Stock
has been set at $10.
00% Series B cumulative convertible preferred stock
at $25 per share for estimated gross proceeds of $100 million.
The company is offering to exchange three new securities: (i) new senior notes in the principal amount of $50 million plus an additional amount for accrued unpaid interest; (ii) $60 million of new senior convertible notes; and (iii) Series A convertible preferred stock
with a liquidation preference of $15 million, for its outstanding convertible notes.
75% mandatory convertible preferred stock
at an offering price of $250 per share.
AMEX:QSC) notified the holders of Questcor's Series B Convertible Preferred Stock
of its intent to redeem all the outstanding Series B shares.
Holders of the Series B and Series C Preferred Stock will receive 24 shares of Series D Convertible Preferred Stock
for each 100 shares of Series B and Series C Preferred Stock outstanding.
Nasdaq: GEPT - News), a leading manufacturer of security technologies for the aviation, law enforcement, industrial and commercial markets, today announced that it has resolved comments received from the Nasdaq Stock Market concerning the Company's private placement sale of its Series D Convertible Preferred Stock
75 shares of Common Stock for each share of Convertible Preferred Stock
29 shares of Series A Convertible Preferred Stock
, par value $0.
AMEX:QSC), a specialty pharmaceutical company that develops and commercializes novel therapeutics for the treatment of neurological disorders, notified the holders of Questcor's Series B Convertible Preferred Stock
of its intent to redeem on January 3, 2006 all outstanding shares of Series B Convertible Preferred Stock